Genetron Health Receives CAP Accreditation For Its Maryland Laboratory
Author: Bill Haddad | June 15, 2022 06:06am
BEIJING, June 15, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced College of American Pathologists (CAP) Accreditation for its laboratory in Maryland, U.S.
Posted In: GTH